Inventor · disambiguated record
Yihong Qiu
Also filed as: QIU YIHONG
16 granted patents·23 pending applications·449 citations·filing 1998–2025
94Inventor score
Top patents by PatentIndex Score
39 records- 0192US6180138B1Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorptionABBOTT LAB·Filed 1999·Granted Jan 30, 2001·134 cites·16 claims
- 0290US6713086B2Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2002·Granted Mar 30, 2004·43 cites·17 claims
- 0388US8541026B2Sustained release formulations of opioid and nonopioid analgesicsQIU YIHONG·Filed 2007·Granted Sep 24, 2013·9 cites·23 claims
- 0487US6150410ApH independent extended release pharmaceutical formulationABBOTT LAB·Filed 2000·Granted Nov 21, 2000·27 cites·30 claims
- 0586US7364752B1Solid dispersion pharamaceutical formulationsABBOTT LAB·Filed 2000·Granted Apr 29, 2008·23 cites·10 claims
- 0683US6528090B2Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2000·Granted Mar 4, 2003·18 cites·7 claims
- 0780US6720004B2Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2002·Granted Apr 13, 2004·10 cites·3 claims
- 0880US6511678B2Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2000·Granted Jan 28, 2003·10 cites·8 claims
- 0979US6383517B1Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorptionABBOTT LAB·Filed 1999·Granted May 7, 2002·55 cites·14 claims
- 1076US6528091B1Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2002·Granted Mar 4, 2003·6 cites·2 claims
- 1174US6368622B2Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorptionABBOTT LAB·Filed 1999·Granted Apr 9, 2002·43 cites·15 claims
- 1272US6033685ATablet for the controlled release of active agentsABBOTT LAB·Filed 1998·Granted Mar 7, 2000·42 cites·19 claims
- 1370US6419953B1Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 1998·Granted Jul 16, 2002·29 cites·16 claims
- 1470US2010021393A1Pharmaceutical Compositions Comprising Effervescent Agents and FenofibrateABBOTT LAB·Filed 2009·Application pending·0 cites
- 1569US2024316040A1Extended release upadacitinib formulationsABBVIE INC·Filed 2021·Application pending·0 cites
- 1669US2024417404A1CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE AS IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTIONBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 1764US2025161302A1Extended release upadacitinib formulationsABBVIE INC·Filed 2025·Application pending·0 cites
- 1862US2004156897A1Controlled release formulation of divalproex sodiumFiled 2004·Application pending·0 cites
- 1962US2004156898A1Controlled release formulation of divalproex sodiumFiled 2004·Application pending·0 cites
- 2061US2014044782A1Controlled release formulations of opioid and nonopioid analgesicsALZA CORP·Filed 2013·Application pending·0 cites
- 2161US2008031901A1Sustained release monoeximic formulations of opioid and nonopioid analgesicsABBOTT LAB·Filed 2007·Application pending·0 cites
- 2260US2013209525A1Controlled release formulations of opioid and nonopioid analgesicsALZA CORP·Filed 2013·Application pending·0 cites
- 2358US9107830B2Inhibitors of crystallization in a solid dispersionFORT JAMES J·Filed 2007·Granted Aug 18, 2015·0 cites·14 claims
- 2457US2013281479A1Sustained release monoeximic formulations of opioid and nonopioid analgesicsABBOTT LAB·Filed 2012·Application pending·0 cites
- 2557US2006251721A1Controlled release formulations of opioid and nonopioid analgesicsCRUZ EVANGELINE·Filed 2006·Application pending·0 cites
- 2657US2024299434A1Uridine triacetate amorphous formulationPHARMA CINQ LLC·Filed 2022·Application pending·0 cites
- 2756US2005158382A1Controlled release formulations of opioid and nonopioid analgesicsFiled 2004·Application pending·0 cites
- 2856US2012251590A1Controlled release formulations of opioid and nonopioid analgesicsCRUZ EVANGELINE·Filed 2012·Application pending·0 cites
- 2955US2025213486A1Solid Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or AdenomyosisABBVIE INC·Filed 2024·Application pending·0 cites
- 3055US2012165358A1Controlled release formulations of opioid and nonopioid analgesicsCRUZ EVANGELINE·Filed 2011·Application pending·0 cites
- 3154US2011166171A1Sustained release monoeximic formulations of opioid and nonopioid analgesicsABBOTT LAB·Filed 2011·Application pending·0 cites
- 3251US2010221293A1Controlled release formulations of opioid and nonopioid analgesicsCRUZ EVANGELINE·Filed 2010·Application pending·0 cites
- 3346US2008031825A1Pharmaceutical Compositions Comprising Effervescent Agents And FenofibrateCHEN YISHENG·Filed 2005·Application pending·0 cites
- 3445US2002127277A1Solid dosage forms of divalproex sodiumFiled 2000·Application pending·0 cites
- 3544US8062664B2Process for preparing formulations of lipid-regulating drugsQIU YIHONG·Filed 2004·Granted Nov 22, 2011·0 cites·16 claims
- 3643US2006177512A1Process for preparing formulations of lipid-regulating drugsQIU YIHONG·Filed 2004·Application pending·0 cites
- 3742US12083227B2Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosisABBVIE INC·Filed 2018·Granted Sep 10, 2024·0 cites·46 claims
- 3838US2002031549A1Controlled release formulation of divalproex sodiumFiled 2001·Application pending·0 cites
- 3938US2002025341A1Controlled release formulation of divalproex sodiumFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yihong Qiu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →